Photo-induced Drug Eruption in a Patient on Combination Simeprevir/sofosbuvir for Hepatitis C
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Borgia F, Cacciola I, Filomia R, Vaccaro M, Squadrito G, Cannavo S Br J Clin Pharmacol. 2017; 83(5):1152-1154.
PMID: 28120401 PMC: 6396847. DOI: 10.1111/bcp.13221.
References
1.
Lawitz E, Sulkowski M, Ghalib R, Rodriguez-Torres M, Younossi Z, Corregidor A
. Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study. Lancet. 2014; 384(9956):1756-65.
DOI: 10.1016/S0140-6736(14)61036-9.
View
2.
Lawitz E, Mangia A, Wyles D, Rodriguez-Torres M, Hassanein T, Gordon S
. Sofosbuvir for previously untreated chronic hepatitis C infection. N Engl J Med. 2013; 368(20):1878-87.
DOI: 10.1056/NEJMoa1214853.
View
3.
Drucker A, Rosen C
. Drug-induced photosensitivity: culprit drugs, management and prevention. Drug Saf. 2011; 34(10):821-37.
DOI: 10.2165/11592780-000000000-00000.
View
4.
Izquierdo L, Helle F, Francois C, Castelain S, Duverlie G, Brochot E
. Simeprevir for the treatment of hepatitis C virus infection. Pharmgenomics Pers Med. 2014; 7:241-9.
PMC: 4157399.
DOI: 10.2147/PGPM.S52715.
View
5.
Jacobson I, Gordon S, Kowdley K, Yoshida E, Rodriguez-Torres M, Sulkowski M
. Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options. N Engl J Med. 2013; 368(20):1867-77.
DOI: 10.1056/NEJMoa1214854.
View